Skip to content
About
About Us
Team
Board of Directors
Scientific Advisors
Investors
Our Science
ATAC Platform
Posters & Publications
Applications
Careers
Join Us
Core Values
News & Events
Press Releases
In the News
Contact
Toggle navigation
About
About Us
Team
Board of Directors
Scientific Advisors
Investors
Our Science
ATAC Platform
Posters & Publications
Applications
Careers
Join Us
Core Values
News & Events
Press Releases
In the News
Contact
In the News
❮ Back to In the News
Avilar Therapeutics launches with $60 million to degrade extracellular targets
❮ Back to In the News
Toggle navigation
Toggle navigation